Minjia Sheng

559 total citations
12 papers, 433 citations indexed

About

Minjia Sheng is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Minjia Sheng has authored 12 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Reproductive Medicine. Recurrent topics in Minjia Sheng's work include Ovarian function and disorders (4 papers), Lymphatic System and Diseases (3 papers) and Kruppel-like factors research (2 papers). Minjia Sheng is often cited by papers focused on Ovarian function and disorders (4 papers), Lymphatic System and Diseases (3 papers) and Kruppel-like factors research (2 papers). Minjia Sheng collaborates with scholars based in China, United States and Germany. Minjia Sheng's co-authors include Jianxin Fu, Brett H. Herzog, J. Michael McDaniel, Lijun Xia, Samuel McGee, Hong Chen, Yanfang Pan, Bernhard Nieswandt, Andrew J. Morris and Stephen J. Wilson and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Minjia Sheng

12 papers receiving 433 citations

Peers

Minjia Sheng

MB

ONCOL

IMMUN

HEMAT

CR

Dorota Lemancewicz Poland

Zamir Brelvi United States

Katrin Friedbichler Austria

Kazuyoshi Hirayama Japan

Gustavo Jacob Lourenço Brazil

Y Miura Japan

Yang Mh Taiwan

Yael Zimra Israel

Laurindo Ferreira da Rocha Brazil

Elvira Avilla Italy

Dorota Lemancewicz Poland

Minjia Sheng

123 ×0.7

MB

98 ×0.6

ONCOL

81 ×0.6

IMMUN

99 ×1.3

HEMAT

44 ×1.0

CR

Citations per year, relative to Minjia Sheng Minjia Sheng (= 1×) peers Dorota Lemancewicz

Countries citing papers authored by Minjia Sheng

Since Specialization

Citations

This map shows the geographic impact of Minjia Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjia Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjia Sheng more than expected).

Fields of papers citing papers by Minjia Sheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minjia Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjia Sheng. The network helps show where Minjia Sheng may publish in the future.

Co-authorship network of co-authors of Minjia Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Minjia Sheng. A scholar is included among the top collaborators of Minjia Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minjia Sheng. Minjia Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Sheng, Minjia, Ran Sun, Jianxin Fu, & Lu Gao. (2024). The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis. BMC Cancer. 24(1). 399–399. 7 indexed citations

2.

Zhao, Yanjie, Xiaochen Zhang, Yankai Xia, et al.. (2020). A Survey Study Reveals the Positive Impact of Oncofertility Knowledge and Attitude on Oncofertility Practice Among Oncologists in China. Journal of Adolescent and Young Adult Oncology. 10(5). 606–613. 6 indexed citations

3.

Sheng, Minjia, et al.. (2020). Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome. Molecular Medicine Reports. 21(5). 2138–2150. 15 indexed citations

4.

Li, Tao, et al.. (2020). Exonuclease 1 (Exo1) Participates in Mammalian Non-Homologous End Joining and Contributes to Drug Resistance in Ovarian Cancer. Medical Science Monitor. 26. e918751–e918751. 27 indexed citations

5.

Wang, Yang, et al.. (2019). A Novel Genes Signature Associated with the Progression of Polycystic Ovary Syndrome. Pathology & Oncology Research. 26(1). 575–582. 13 indexed citations

6.

Miao, Sheng, et al.. (2019). Probabilistic guided polycystic ovary syndrome recognition using learned quality kernel. Journal of Visual Communication and Image Representation. 63. 102587–102587. 1 indexed citations

7.

Sheng, Minjia, Feng Shi, Yanjie Zhao, et al.. (2018). Dysfunctional phagocytosis capacity, granulocyte recruitment and inflammatory factor secretion of Kupffer cells in diabetes mellitus reversed by Lidocaine. Diabetes Metabolic Syndrome and Obesity. Volume 11. 827–834. 4 indexed citations

8.

Liu, Junbao, et al.. (2016). Inhibition of microRNA-383 has tumor suppressive effect in human epithelial ovarian cancer through the action on caspase-2 gene. Biomedicine & Pharmacotherapy. 83. 1286–1294. 23 indexed citations

9.

Song, Kai, Brett H. Herzog, Jianxin Fu, et al.. (2015). Loss of Core 1-derived O-Glycans Decreases Breast Cancer Development in Mice. Journal of Biological Chemistry. 290(33). 20159–20166. 26 indexed citations

10.

Sheng, Minjia, Yanjie Zhao, Aichen Zhang, Liyan Wang, & Guizhen Zhang. (2014). The effect of LfcinB9 on human ovarian cancer cell SK-OV-3 is mediated by inducing apoptosis. Journal of Peptide Science. 20(10). 803–810. 11 indexed citations

11.

Song, Kai, Brett H. Herzog, Minjia Sheng, et al.. (2013). Lenalidomide Inhibits Lymphangiogenesis in Preclinical Models of Mantle Cell Lymphoma. Cancer Research. 73(24). 7254–7264. 50 indexed citations

12.

Herzog, Brett H., Jianxin Fu, Stephen J. Wilson, et al.. (2013). Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature. 502(7469). 105–109. 250 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact